Screener
Denali Therapeutics Inc. DNLI Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $4.08B.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
FAQ
- What is Denali Therapeutics Inc.'s market capitalization?
- Denali Therapeutics Inc. (DNLI) reported market capitalization of $4.08B in Q2 2026.
- How has Denali Therapeutics Inc.'s market capitalization changed year-over-year?
- Denali Therapeutics Inc.'s market capitalization increased by 95.1% year-over-year, from $2.09B to $4.08B.
- What is the long-term trend for Denali Therapeutics Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Denali Therapeutics Inc.'s market capitalization has grown at a -24.1% compound annual growth rate (CAGR), from $10.23B to $2.58B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Denali Therapeutics Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude